What oral antibiotics cover Group B strep (Streptococcus agalactiae)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Antibiotics for Group B Streptococcus (Streptococcus agalactiae)

Penicillin and amoxicillin are the first-line oral antibiotics for treating Group B Streptococcus (GBS) infections, with clindamycin as the primary alternative for penicillin-allergic patients, provided susceptibility testing confirms effectiveness. 1

First-Line Oral Antibiotics

  • Penicillin V: First choice due to its narrow spectrum of activity, which minimizes disruption to normal flora and reduces risk of developing antibiotic resistance 2

    • Adult dosing: 250 mg four times daily or 500 mg twice daily for 10 days
    • Pediatric dosing: 250 mg two to three times daily for 10 days
  • Amoxicillin: Effective alternative to penicillin with similar efficacy 2

    • Adult dosing: 500 mg three times daily for 10 days
    • Pediatric dosing: 50 mg/kg once daily (maximum 1000 mg) or 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days

Alternatives for Penicillin-Allergic Patients

For Non-Anaphylactic Penicillin Allergy:

  • Cefazolin (oral cephalosporin alternatives like cephalexin or cefuroxime may be used) 2
    • Note: About 10% of patients with penicillin allergy may also have hypersensitivity reactions to cephalosporins 2

For Anaphylactic Penicillin Allergy:

  • Clindamycin: 300-450 mg orally three times daily for 10 days 3, 1

    • Important: Susceptibility testing is essential as resistance rates are increasing 4, 5
    • FDA-approved for treating infections caused by Streptococcus agalactiae (GBS) 1
  • Azithromycin: 500 mg once daily for 5 days 3

    • Resistance rates are high (31% in some studies) 5
    • Should only be used when susceptibility is confirmed
  • Vancomycin: Reserved for severe infections when other options aren't viable 2

    • Typically administered intravenously rather than orally

Antibiotic Resistance Considerations

  • GBS remains largely susceptible to penicillins, though there have been reports of reduced susceptibility in some regions 4
  • Resistance to second-line antibiotics is increasing:
    • Up to 31% resistance to azithromycin 5
    • Up to 19% resistance to clindamycin 5
  • Susceptibility testing is crucial before using non-beta-lactam antibiotics 2, 4

Clinical Pearls and Pitfalls

  • Pitfall: Oral antibiotics given before labor do not effectively eliminate GBS colonization and should not be used for this purpose 6
  • Pitfall: Using broad-spectrum antibiotics unnecessarily can promote resistance development 4
  • Pitfall: Assuming all GBS isolates are susceptible to clindamycin or erythromycin without testing 2, 5
  • Pearl: A full 10-day course of antibiotics is essential for complete eradication, except for azithromycin which is given for 5 days due to its prolonged tissue persistence 3

Special Populations

  • Pregnancy: For GBS prophylaxis during labor, intravenous antibiotics are preferred over oral options 7
  • Renal Impairment: No dosage adjustment needed for clindamycin 1
  • Elderly: Clindamycin elimination half-life increases to approximately 4 hours in elderly patients compared to 3.2 hours in younger adults, but dosage adjustment is not necessary with normal hepatic and age-adjusted renal function 1

Remember that antibiotic selection should be guided by susceptibility testing whenever possible, especially for non-penicillin options, as resistance patterns continue to evolve.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pharyngitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Research

Prenatal antibiotic treatment does not decrease group B streptococcus colonization at delivery.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2008

Research

Group B Streptococcus in Pregnancy.

Obstetrics and gynecology clinics of North America, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.